drugset / Trial / NCT00384306

Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease

NCT00384306

Phase 1 Completed 9 enrolled GlaxoSmithKline University of Cambridge · collab
Non-randomizedCrossoverOpen-labelTreatment

Summary

The aim of this study is to establish associations between blood and urine markers of bone metabolism with histomorphometric changes (changes in the actual bone structure) resulting from short term oral prednisolone treatment in patients with COPD (chronic obstructive pulmonary disease).

Timeline

Start
2004-06
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified Oral